Tilray周一早盘下跌5.9%，部分回吐上涨幅

Group 1 - The core point of the article highlights the decline in Tilray's stock price by 5.9% after a significant increase of 44% the previous Friday, driven by news regarding potential reclassification of cannabis by federal agencies [1] - The stock's surge was attributed to a report that President Trump directed federal agencies to reclassify cannabis from a Schedule I controlled substance to a less restrictive Schedule III [1]